Log In
BCIQ
Print this Print this
 

OXY111A

  Manage Alerts
Collapse Summary General Information
Company NormOxys Inc.
DescriptionAllosteric modulator of affinity of oxygen to hemoglobin
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationCongestive heart failure (CHF)
Indication DetailsTreat congestive heart failure (CHF)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today